JOINN

6127
22.1801.51% ( -0.340 )
Delay Closed: Nov 16, 16:08:11

Overview

JOINN (6127)

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It o...

Open
22.880
High
22.880
Low
21.800
Prev. Close
22.520
Volume
2.60M
Turnover
57.68M
Avg Price
22.182
Bid/Ask Ratio
-87.10%
Amplitude
4.80%
52wk High
32.580
Volume Ratio
0.10
Turnover Ratio
2.19%
52wk Low
14.992
HK Mkt Cap
2.64B
Market CapHKD
16.62B
P/ETTM
12.44
P/EDynamic
11.51
P/EStatic
--
EPSTTM
1.78
EPSDynamic
1.93
EPSStatic
--
BVPS
14.25
P/B
1.56
HK Shares
119.00M
Dividend YieldTTM
0.62%
DividendTTM
0.13786
Shares
749.35M
Min lot size
100
Currency
HKD

JOINN Analyst Rating

View more

Forecast & Rating

Nov 5, 2026
Price forecast
HK$26.4919.44%
Forecast & RatingBuy
6analysts
  • Strong buy50.00%
  • Buy0.00%
  • Hold33.33%
  • Sell0.00%
  • Strong sell16.67%

Daily Events

  1. Nov, 13

    JOINN Laboratories opened at HK$24.20 and slid through both the morning and afternoon sessions to close at HK$22.52, down 7.70% and near the intraday low of HK$22.36, unwinding the 4.39% weekly gain flagged in the prior weekly recap; 3.63 million shares traded for HK$83.76 million of turnover, a 3.05% turnover rate. The move contrasts with Q3 2026 fundamentals: revenue of HK$566.4 million rose 63.77% year on year, net profit of HK$213.1 million jumped 886.11%, and net margin reached 37.63%, while H1 orders nearly doubling had earlier carried the stock to a 52-week high of HK$32.58. At HK$22.52 the shares trade at 12.63x PE and 1.58x PB, and the consensus target price was raised 22.30% to HK$23.46, above spot. The stock nonetheless sits below its 20-day moving average of HK$23.91 and 60-day of HK$25.27, 30.88% below the 52-week high, with the year-to-date gain trimmed to 12.83%.

  2. Nov, 10

    Joinn Laboratories rose 2.54% to HK$24.18 as Hong Kong CXO and innovative-drug names rallied together; the stock spiked to HK$24.78 in the morning session, slid to HK$23.82 by 14:46 BJ time, then recovered into the close on 4.44 million shares worth about HK$108 million. WuXi AppTec and peers gained more than 10% intraday, pulling flows back into the sector. The Q3 2026 print backs the move: revenue of HK$566 million, up 63.77% year on year, net profit of HK$213 million, up 886.11%, and a 37.63% net margin, a clear step up from Q2's 7.19% revenue growth. CMB International lifted its target price to HK$30. Even so, the price sits below both MA20 of HK$24.61 and MA60 of HK$25.41, 25.78% under the 52-week high of HK$32.58, while up 21.14% year to date at 13.56x PE and 1.70x PB.

  3. Nov, 9

    JOINN Laboratories reversed an early rally, touching HK$24.86 at 10:01 before sliding to close at HK$23.52, down 1.01% and at the session low on HK$664 million turnover, as a strong Q3 report — net profit of HK$213 million, up 886% year on year, on revenue of HK$566 million, up 63.77% — failed to sustain momentum. The stock now trades below its MA20 of HK$24.92 and MA60 of HK$25.42, still 27.81% below the 52-week high of HK$32.58 reached on 5 October, though it remains up 17.84% year to date and 55.45% above the March low of HK$15.13. CMB International carries a HK$30 target with a Buy rating while Morgan Stanley reiterated Hold; though the founder Zhou Zhiwen's stake sale of over RMB1.4 billion remains a sentiment overhang.

  4. Nov, 6

    JOINN Laboratories (6127.HK) traced a spike-and-fade pattern, briefly touching HK$23.960 at 09:53 before sliding to a HK$23.060 afternoon low at 13:21 and closing at HK$23.760, down 3.1% from the previous close of HK$24.520, giving back part of the 12% surge scored during the recent CXO sector rally. The retreat contrasts with strong Q3 results: revenue of HK$566.4 million rose 63.8% year on year and net profit of HK$213.1 million rose 886%, lifting nine-month profit above HK$900 million. Even so, the close sits below the 20-day moving average of HK$25.306 and the 60-day average of HK$25.452, 27.1% below the 52-week high of HK$32.58, with year-to-date gains of 19.0%. CMB International raised its target price to HK$30. Turnover of HK$91.7 million and a 3.28% turnover rate indicate the afternoon rebound drew limited volume confirmation.

  5. Nov, 4

    A broad bid across Hong Kong pharmaceutical and CXO names lifted JOINN Laboratories from a soft 21.00 open to a 24.32 close, up 15.2% and marking the session high, on 11.3 million shares worth HK$257 million and a 9.5% turnover rate after a morning dip to HK$20.92. The advance tracked a sector-wide rally in which WuXi AppTec and peers gained over 10%, amplified by first-three-quarter net profit of roughly RMB930 million, up about 10.52 times year on year, with third-quarter profit alone more than eightfold higher; CMB International kept a Buy rating. Even so, the stock remains below its MA20 of HK$25.87 and MA60 of HK$25.51, about 25.35% beneath the October 5 52-week high of HK$32.58, while up 21.84% year to date at 13.6x PE, and founder Zhou Zhiwen's disposal of over RMB1.4 billion in shares is a counterweight.

News

Bullish vs. Bearish — Last 3 Months

7.9k followers · 0 opinions
▲Bullish50%
50%Bearish▼